A Prospective Analysis of the Efficacy of Allosync Expand and Autograft Bone Graft in Open Lumbar Spinal Fusion
Part of paid clinical trials in Southfield, Michigan.
- Sponsor
- Research Source
- Study ID
- NCT06415110
- Status
- Enrolling By Invitation
Conditions
- Spondylolisthesis, Grade 1
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Allosync Expand — DEVICEAllosync Expand is used in lumbar posterolateral arthrodesis at 1-3 contiguous levels (L1-S1)
Study Details
The purpose of this study is to assess the radiographic and clinical outcomes of spinal fusion following use of Allosync Expand and autograft bone graft.
Key Dates
- Start date
- Jun 5, 2024
- Status verified
- Aug 2025
- Primary completion
- May 31, 2026
- Completion
- May 31, 2027
Study Design
- Enrollment
- 40 participants (estimated)
Arms
- Arm: Allosync ExpandAll enrolled patients will received Allosync Expand at 1-3 contiguous levels (L1-S1).
Primary Outcome Measure
Lumbar fusion rate assessed via CT [ Time Frame: 12 months post surgery ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Michigan Orthopaedic Surgeons | Southfield | Michigan | 48033 | - |
Find similar trials in Southfield, MI
By research site